Genetic Markers of Inflammation and Their Role in Cardiovascular Disease

Canadian Journal of Cardiology

Volumn 29, Issue 1, 2013, Pages 67-74

  Raman, Kripa ^a,b,c   Chong, Michael ^a,b   Akhtar Danesh, Gileh Gol ^a,b   D'Mello, Matthew ^a,b   Hasso, Ranya ^a,b   Ross, Stephanie ^a,d   Xu, Fangzhou ^a,b   Paré, Guillaume ^a,b,c,d  

^a MCMASTER UNIVERSITY   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

^c MCMASTER UNIVERSITY   (Canada)

^d MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; LEPTIN; PADGEM PROTEIN;

ATHEROSCLEROSIS; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CYTOKINE RELEASE; DISEASE ASSOCIATION; GENE INTERACTION; GENE LOCUS; GENETIC ASSOCIATION; GENETIC MARKER; GENETIC VARIABILITY; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; INFLAMMATION; PROTEIN EXPRESSION; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM;

BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; GENETIC MARKERS; GENOME-WIDE ASSOCIATION STUDY; HUMANS; INFLAMMATION;

EID: 84871409798     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cjca.2012.06.025     Document Type: Review

References (64)

1. Hansson G.K., Hermansson A. The immune system in atherosclerosis. Nat Immunol 2011, 12:204-212.
2. Hansson G.K., Libby P. The immune response in atherosclerosis: a double-edged sword. Nat Rev Immunol 2006, 6:508-519.
3. Ridker P.M. Cardiology Patient Page. C-reactive protein: a simple test to help predict risk of heart attack and stroke. Circulation 2003, 108:e81-e85.
4. Danesh J., Wheeler J.G., Hirschfield G.M., et al. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. New Engl J Med 2004, 350:1387-1397.
5. de Craen A.J., Posthuma D., Remarque E.J., van den Biggelaar A.H., Westendorp R.G., Boomsma D.I. Heritability estimates of innate immunity: an extended twin study. Genes Immun 2005, 6:167-170.
6. de Maat M.P., Bladbjerg E.M., Hjelmborg J.B., Bathum L., Jespersen J., Christensen K. Genetic influence on inflammation variables in the elderly. Arterioscler Thromb Vasc Biol 2004, 24:2168-2173.
7. Jermendy G., Horvath T., Littvay L., Steinbach R., Jermendy A.L., Tarnoki A.D., et al. Effect of genetic and environmental influences on cardiometabolic risk factors: a twin study. Cardiovasc Diabetol 2011, 10:96.
8. MacGregor A.J., Gallimore J.R., Spector T.D., Pepys M.B. Genetic effects on baseline values of C-reactive protein and serum amyloid a protein: a comparison of monozygotic and dizygotic twins. Clin Chem 2004, 50:130-134.
9. Raggi P., Su S., Karohl C., Veledar E., Rojas-Campos E., Vaccarino V. Heritability of renal function and inflammatory markers in adult male twins. Am J Nephrol 2010, 32:317-323.
10. Lawlor D.A., Harbord R.M., Sterne J.A., Timpson N., Davey Smith G. Mendelian randomization: using genes as instruments for making causal inferences in epidemiology. Stat Med 2008, 27:1133-1163.
11. Tillett W.S., Francis T. Serological reactions in pneumonia with a non-protein somatic fraction of pneumococcus. J Exp Med 1930, 52:561-571.
12. Yasojima K., Schwab C., McGeer E.G., McGeer P.L. Generation of C-reactive protein and complement components in atherosclerotic plaques. Am J Pathol 2001, 158:1039-1051.
13. Teoh H., Quan A., Lovren F., Wang G., Tirgari S., Szmitko P.E., et al. Impaired endothelial function in C-reactive protein overexpressing mice. Atherosclerosis 2008, 201:318-325.
14. Verma S., Kuliszewski M.A., Li S.H., et al. C-reactive protein attenuates endothelial progenitor cell survival, differentiation, and function: further evidence of a mechanistic link between C-reactive protein and cardiovascular disease. Circulation 2004, 109:2058-2067.
15. Pasceri V., Willerson J.T., Yeh E.T. Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation 2000, 102:2165-2168.
16. Chang M.K., Binder C.J., Torzewski M., Witztum J.L. C-reactive protein binds to both oxidized LDL and apoptotic cells through recognition of a common ligand: phosphorylcholine of oxidized phospholipids. Proc Natl Acad Sci U S A 2002, 99:13043-13048.
17. Bhakdi S., Torzewski M., Paprotka K., et al. Possible protective role for C-reactive protein in atherogenesis: complement activation by modified lipoproteins halts before detrimental terminal sequence. Circulation 2004, 109:1870-1876.
18. Rowe I.F., Soutar A.K., Trayner I.M., Thompson G.R., Pepys M.B. Circulating human C-reactive protein binds very low density lipoproteins. Clin Exp Immunol 1984, 58:237-244.
19. Zee R.Y., Ridker P.M. Polymorphism in the human C-reactive protein (CRP) gene, plasma concentrations of CRP, and the risk of future arterial thrombosis. Atherosclerosis 2002, 162:217-219.
20. Lange L.A., Carlson C.S., Hindorff L.A., et al. Association of polymorphisms in the CRP gene with circulating C-reactive protein levels and cardiovascular events. JAMA 2006, 296:2703-2711.
21. Ridker P.M., Pare G., Parker A., et al. Loci related to metabolic-syndrome pathways including LEPR, HNF1A, IL6R, and GCKR associate with plasma C-reactive protein: the Women's Genome Health Study. Am J Hum Genet 2008, 82:1185-1192.
22. Dehghan A., Dupuis J., Barbalic M., et al. Meta-analysis of genome-wide association studies in >80 000 subjects identifies multiple loci for C-reactive protein levels. Circulation 2011, 123:731-738.
23. Berbee J.F., Havekes L.M., Rensen P.C. Apolipoproteins modulate the inflammatory response to lipopolysaccharide. J Endotoxin Res 2005, 11:97-103.
24. McDonald T.J., Shields B.M., Lawry J., et al. High-sensitivity CRP discriminates HNF1A-MODY from other subtypes of diabetes. Diabetes Care 2011, 34:1860-1862.
25. Yamagata K., Oda N., Kaisaki P.J., et al. Mutations in the hepatocyte nuclear factor-1alpha gene in maturity-onset diabetes of the young (MODY3). Nature 1996, 384:455-458.
26. Pare G., Cook N.R., Ridker P.M., Chasman D.I. On the use of variance per genotype as a tool to identify quantitative trait interaction effects: a report from the Women's Genome Health Study. PLoS Genet 2010, 6. e1000981.
27. Couillard C., Mauriege P., Prud'homme D., et al. Plasma leptin concentrations: gender differences and associations with metabolic risk factors for cardiovascular disease. Diabetologia 1997, 40:1178-1184.
28. Rosenbaum M., Nicolson M., Hirsch J., et al. Effects of gender, body composition, and menopause on plasma concentrations of leptin. J Clin Endocrinol Metab 1996, 81:3424-3427.
29. Farooqi S., O'Rahilly S. Genetics of obesity in humans. Endocr Rev 2006, 27:710-718.
30. Chen K., Li F., Li J., et al. Induction of leptin resistance through direct interaction of C-reactive protein with leptin. Nat Med 2006, 12:425-432.
31. Wensley F., Gao P., Burgess S., et al. Association between C reactive protein and coronary heart disease: mendelian randomisation analysis based on individual participant data. BMJ 2011, 342:d548.
32. Zacho J., Tybjaerg-Hansen A., Jensen J.S., Grande P., Sillesen H., Nordestgaard B.G. Genetically elevated C-reactive protein and ischemic vascular disease. N Engl J Med 2008, 359:1897-1908.
33. Elliott P., Chambers J.C., Zhang W., Clarke R., Hopewell J.C., Peden J.F., et al. Genetic loci associated with C-reactive protein levels and risk of coronary heart disease. JAMA 2009, 302:37-48.
34. Verzilli C., Shah T., Casas J.P., et al. Bayesian meta-analysis of genetic association studies with different sets of markers. Am J Hum Genet 2008, 82:859-872.
35. Miller D.T., Zee R.Y., Suk Danik J., et al. Association of common CRP gene variants with CRP levels and cardiovascular events. Ann Hum Genet 2005, 69:623-638.
36. McDermott M.M., Lloyd-Jones D.M. The role of biomarkers and genetics in peripheral arterial disease. J Am Coll Cardiol 2009, 54:1228-1237.
37. Nakashima Y., Raines E.W., Plump A.S., Breslow J.L., Ross R. Upregulation of VCAM-1 and ICAM-1 at atherosclerosis-prone sites on the endothelium in the ApoE-deficient mouse. Arterioscler Thromb Vasc Biol 1998, 18:842-851.
38. Gross M.D., Bielinski S.J., Suarez-Lopez J.R., et al. Circulating soluble intercellular adhesion molecule 1 and subclinical atherosclerosis: the Coronary Artery Risk Development in Young Adults Study. Clin Chem 2012, 58:411-420.
39. Paré G., Ridker P.M., Rose L., et al. Genome-wide association analysis of soluble ICAM-1 concentration reveals novel associations at the NFKBIK, PNPLA3, RELA, and SH2B3 loci. PLoS Genet 2011, 7. e1001374.
40. Blann A.D., Daly R.J., Amiral J. The influence of age, gender and ABO blood group on soluble endothelial cell markers and adhesion molecules. Br J Haematol 1996, 92:498-500.
41. Barbalic M., Dupuis J., Dehghan A., et al. Large-scale genomic studies reveal central role of ABO in sP-selectin and sICAM-1 levels. Hum Mol Genet 2010, 19:1863-1872.
42. Pare G., Chasman D.I., Kellogg M., et al. Novel association of ABO histo-blood group antigen with soluble ICAM-1: results of a genome-wide association study of 6,578 women. PLoS Genet 2008, 4. e1000118.
43. Collins R.G., Velji R., Guevara N.V., Hicks M.J., Chan L., Beaudet A.L. P-Selectin or intercellular adhesion molecule (ICAM)-1 deficiency substantially protects against atherosclerosis in apolipoprotein E-deficient mice. J Exp Med 2000, 191:189-194.
44. Gudbjartsson D.F., Bjornsdottir U.S., Halapi E., et al. Sequence variants affecting eosinophil numbers associate with asthma and myocardial infarction. Nat Genet 2009, 41:342-347.
45. Devalliere J., Charreau B. The adaptor Lnk (SH2B3): an emerging regulator in vascular cells and a link between immune and inflammatory signaling. Biochem Pharmacol 2011, 82:1391-1402.
46. Ledebur H.C., Parks T.P. Transcriptional regulation of the intercellular adhesion molecule-1 gene by inflammatory cytokines in human endothelial cells. Essential roles of a variant NF-kappa B site and p65 homodimers. J Biol Chem 1995, 270:933-943.
47. Romano M., Sironi M., Toniatti C., et al. Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment. Immunity 1997, 6:315-325.
48. Oleksowicz L., Mrowiec Z., Zuckerman D., Isaacs R., Dutcher J., Puszkin E. Platelet activation induced by interleukin-6: evidence for a mechanism involving arachidonic acid metabolism. Thromb Haemost 1994, 72:302-308.
49. Ridker P.M., Rifai N., Stampfer M.J., Hennekens C.H. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation 2000, 101:1767-1772.
50. Naitza S., Porcu E., Steri M., et al. A genome-wide association scan on the levels of markers of inflammation in Sardinians reveals associations that underpin its complex regulation. PLoS Genet 2012, 8. e1002480.
51. Sarwar N., Butterworth A.S., Freitag D.F., et al. Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies. Lancet 2012, 379:1205-1213.
52. Mullberg J., Oberthur W., Lottspeich F., et al. The soluble human IL-6 receptor. Mutational characterization of the proteolytic cleavage site. J Immunol 1994, 152:4958-4968.
53. Reich D., Patterson N., Ramesh V., et al. Admixture mapping of an allele affecting interleukin 6 soluble receptor and interleukin 6 levels. Am J Hum Genet 2007, 80:716-726.
54. Dong Z.M., Chapman S.M., Brown A.A., Frenette P.S., Hynes R.O., Wagner D.D. The combined role of P- and E-selectins in atherosclerosis. J Clin Invest 1998, 102:145-152.
55. Blann A.D., Nadar S.K., Lip G.Y. The adhesion molecule P-selectin and cardiovascular disease. Eur Heart J 2003, 24:2166-2179.
56. Herrmann S.M., Ricard S., Nicaud V., et al. The P-selectin gene is highly polymorphic: reduced frequency of the Pro715 allele carriers in patients with myocardial infarction. Hum Mol Genet 1998, 7:1277-1284.
57. Kiechl S., Pare G., Barbalic M., et al. Association of variation at the ABO locus with circulating levels of soluble intercellular adhesion molecule-1, soluble P-selectin, and soluble E-selectin: a meta-analysis. Circ Cardiovasc Genet 2011, 4:681-686.
58. Koenig W., Sund M., Frohlich M., Lowel H., Hutchinson W.L., Pepys M.B. Refinement of the association of serum C-reactive protein concentration and coronary heart disease risk by correction for within-subject variation over time: the MONICA Augsburg studies, 1984 and 1987. Am J Epidemiol 2003, 158:357-364.
59. Davies R.W., Wells G.A., Stewart A.F., et al. A genome-wide association study for coronary artery disease identifies a novel susceptibility locus in the major histocompatibility complex. Circ Cardiovasc Genet 2012, 5:217-225.
60. Swanberg M., Lidman O., Padyukov L., et al. MHC2TA is associated with differential MHC molecule expression and susceptibility to rheumatoid arthritis, multiple sclerosis and myocardial infarction. Nat Genet 2005, 37:486-494.
61. Hamid Y.H., Urhammer S.A., Jensen D.P., et al. Variation in the interleukin-6 receptor gene associates with type 2 diabetes in Danish whites. Diabetes 2004, 53:3342-3345.
62. Ferreira M.A., Matheson M.C., Duffy D.L., et al. Identification of IL6R and chromosome 11q13.5 as risk loci for asthma. Lancet 2011, 378:1006-1014.
63. Stephens O.W., Zhang Q., Qu P., et al. An intermediate-risk multiple myeloma subgroup is defined by sIL-6r: levels synergistically increase with incidence of SNP rs2228145 and 1q21 amplification. Blood 2012, 119:503-512.
64. Rose-John S., Scheller J., Elson G., Jones S.A. Interleukin-6 biology is coordinated by membrane-bound and soluble receptors: role in inflammation and cancer. J Leukoc Biol 2006, 80:227-236.